The niche of One Health approaches in Lassa fever surveillance and control.


Journal

Annals of clinical microbiology and antimicrobials
ISSN: 1476-0711
Titre abrégé: Ann Clin Microbiol Antimicrob
Pays: England
ID NLM: 101152152

Informations de publication

Date de publication:
24 Apr 2021
Historique:
received: 13 11 2020
accepted: 12 04 2021
entrez: 25 4 2021
pubmed: 26 4 2021
medline: 5 10 2021
Statut: epublish

Résumé

Lassa fever (LF), a zoonotic illness, represents a public health burden in West African countries where the Lassa virus (LASV) circulates among rodents. Human exposure hinges significantly on LASV ecology, which is in turn shaped by various parameters such as weather seasonality and even virus and rodent-host genetics. Furthermore, human behaviour, despite playing a key role in the zoonotic nature of the disease, critically affects either the spread or control of human-to-human transmission. Previous estimations on LF burden date from the 80s and it is unclear how the population expansion and the improvement on diagnostics and surveillance methods have affected such predictions. Although recent data have contributed to the awareness of epidemics, the real impact of LF in West African communities will only be possible with the intensification of interdisciplinary efforts in research and public health approaches. This review discusses the causes and consequences of LF from a One Health perspective, and how the application of this concept can improve the surveillance and control of this disease in West Africa.

Identifiants

pubmed: 33894784
doi: 10.1186/s12941-021-00431-0
pii: 10.1186/s12941-021-00431-0
pmc: PMC8067790
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

29

Subventions

Organisme : European and Developing Countries Clinical Trials Partnership
ID : RIA2016E-1609
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/M009513/1
Pays : United Kingdom

Références

Bull World Health Organ. 1975;52(4-6):609-13
pubmed: 1085216
Annu Rev Pathol. 2013 Jan 24;8:411-40
pubmed: 23121052
PLoS Comput Biol. 2021 Mar 3;17(3):e1008811
pubmed: 33657095
Am J Trop Med Hyg. 2017 Apr;96(4):935-943
pubmed: 28167603
Lancet. 2018 Feb 24;391(10122):728
pubmed: 29486937
PLoS One. 2012;7(5):e37068
pubmed: 22615894
Lancet Infect Dis. 2019 Dec;19(12):1371-1378
pubmed: 31588039
Onderstepoort J Vet Res. 2014 Apr 23;81(2):E1-4
pubmed: 25005349
Antiviral Res. 2018 Nov;159:63-67
pubmed: 30261226
Virol J. 2016 Oct 3;13(1):163
pubmed: 27716429
Front Public Health. 2019 Jun 25;7:170
pubmed: 31294014
Emerg Infect Dis. 2019 May;25(5):999-1002
pubmed: 31002054
J Vector Borne Dis. 2007 Mar;44(1):1-11
pubmed: 17378212
Anim Health Res Rev. 2013 Dec;14(2):127-32
pubmed: 24152741
PLoS Negl Trop Dis. 2017 Jul 3;11(7):e0005711
pubmed: 28671959
BMJ Glob Health. 2019 Feb 7;4(Suppl 2):e001116
pubmed: 30899575
Bull World Health Organ. 1975;52(4-6):577-92
pubmed: 782738
Emerg Microbes Infect. 2020 Dec;9(1):1055-1064
pubmed: 32459576
Vector Borne Zoonotic Dis. 2001 Winter;1(4):269-81
pubmed: 12653127
Int J Infect Dis. 2020 Mar;92:49-52
pubmed: 31866549
Trans R Soc Trop Med Hyg. 2015 Aug;109(8):483-92
pubmed: 26085474
Br Med J. 1977 May 28;1(6073):1399-402
pubmed: 861652
Emerg Infect Dis. 2013 Nov;19(11):1832-5
pubmed: 24188212
Emerg Infect Dis. 2019 Feb;25(2):245-248
pubmed: 30666924
Front Zool. 2005 Oct 20;2:16
pubmed: 16242022
Curr Opin Virol. 2019 Aug;37:105-111
pubmed: 31472333
Front Microbiol. 2018 Aug 03;9:1751
pubmed: 30123198
Emerg Infect Dis. 2019 May;25(5):1026-1027
pubmed: 30807268
Immunogenetics. 2010 Jan;62(1):59-64
pubmed: 19953242
Pathog Glob Health. 2017 Sep;111(6):276-288
pubmed: 28875769
Bull World Health Organ. 1975;52(4-6):637-44
pubmed: 1085219
Biology (Basel). 2020 Feb 07;9(2):
pubmed: 32046182
Ecohealth. 2016 Jun;13(2):234-47
pubmed: 26895631
Emerg Infect Dis. 2016 Apr;22(4):694-7
pubmed: 26982388
PLoS Negl Trop Dis. 2018 Feb 22;12(2):e0006187
pubmed: 29470486
J Infect Dis. 2017 Jun 15;215(12):1862-1872
pubmed: 28863472
Pan Afr Med J. 2018 May 24;30:56
pubmed: 30197747
Trans R Soc Trop Med Hyg. 1984;78(6):761-3
pubmed: 6398529
Bull World Health Organ. 1975;52(4-6):523-34
pubmed: 821625
Heredity (Edinb). 2006 Jan;96(1):7-21
pubmed: 16094301
Vector Borne Zoonotic Dis. 2014 Sep;14(9):665-74
pubmed: 25229705
Viruses. 2020 Mar 14;12(3):
pubmed: 32183319
PLoS One. 2012;7(5):e36586
pubmed: 22574186
Viruses. 2020 Mar 31;12(4):
pubmed: 32244402
BMC Infect Dis. 2019 Jul 11;19(1):610
pubmed: 31296177
BMJ. 1995 Sep 30;311(7009):857-9
pubmed: 7580496
PLoS Negl Trop Dis. 2014 Mar 20;8(3):e2748
pubmed: 24651047
Emerg Infect Dis. 2016 Apr;22(4):657-63
pubmed: 26981786
Science. 2019 Jan 4;363(6422):74-77
pubmed: 30606844
Emerg Infect Dis. 2019 Jun;25(6):1066-1074
pubmed: 31107222
Emerg Infect Dis. 2019 Oct;25(10):1977-1979
pubmed: 31365854
Crit Rev Clin Lab Sci. 2004;41(4):339-90
pubmed: 15487592
Science. 1974 Jul 19;185(4147):263-5
pubmed: 4833828
Glob Chang Biol. 2019 Nov;25(11):3720-3730
pubmed: 31376191
Sci Rep. 2016 Feb 25;6:21977
pubmed: 26911443
Parasit Vectors. 2018 Jul 13;11(1):416
pubmed: 30005641
PLoS Negl Trop Dis. 2009;3(3):e388
pubmed: 19255625
J Clin Microbiol. 2011 Mar;49(3):1157-61
pubmed: 21191050
J Infect Dis. 2001 Aug 1;184(3):345-9
pubmed: 11443561
Infect Dis Poverty. 2018 Apr 28;7(1):37
pubmed: 29703243
Immunogenetics. 2019 Sep;71(8-9):575-587
pubmed: 31520134
J Infect Dis. 1987 Mar;155(3):437-44
pubmed: 3805771
N Engl J Med. 2018 Nov 1;379(18):1745-1753
pubmed: 30332564
Clin Med (Lond). 2009 Jun;9(3):259-60
pubmed: 19634392
Euro Surveill. 2020 Apr;25(15):
pubmed: 32317052
Immunogenetics. 2004 Sep;56(6):420-6
pubmed: 15351919
Infect Genet Evol. 2008 Jul;8(4):450-8
pubmed: 17693139
Afr J Lab Med. 2020 Aug 26;9(2):1019
pubmed: 32934913
Am J Trop Med Hyg. 1996 Dec;55(6):661-6
pubmed: 9025695
Integr Zool. 2007 Dec;2(4):220-32
pubmed: 21396039
Cell. 2015 Aug 13;162(4):738-50
pubmed: 26276630
Sci Rep. 2016 Dec 12;6:38490
pubmed: 27941813
Euro Surveill. 2019 May;24(20):
pubmed: 31115314
PLoS Negl Trop Dis. 2012;6(9):e1839
pubmed: 23029594
Vector Borne Zoonotic Dis. 2007 Summer;7(2):119-28
pubmed: 17627428
Philos Trans R Soc Lond B Biol Sci. 2019 Jun 24;374(1775):20180268
pubmed: 31056054
Vector Borne Zoonotic Dis. 2008 Spring;8(1):41-8
pubmed: 18237265
Emerg Infect Dis. 2000 Sep-Oct;6(5):466-76
pubmed: 10998376
Ecohealth. 2018 Jun;15(2):348-359
pubmed: 29572697
Int J Infect Dis. 2019 Jun;83:88-94
pubmed: 30930184
Am J Trop Med Hyg. 2019 Mar;100(3):647-651
pubmed: 30693858
Sci Rep. 2016 May 03;6:25280
pubmed: 27140942

Auteurs

Liã Bárbara Arruda (LB)

Centre for Clinical Microbiology, Division of Infection and Immunity, University College London, London, UK. l.arruda@ucl.ac.uk.

Najmul Haider (N)

The Royal Veterinary College, University of London, Hatfield, UK.

Ayodeji Olayemi (A)

Natural History Museum, Obafemi Awolowo University, Ile Ife, Nigeria.

David Simons (D)

The Royal Veterinary College, University of London, Hatfield, UK.

Deborah Ehichioya (D)

Institute of Lassa Fever Research and Control, Irrua Specialist Teaching Hospital, Irrua, Nigeria.
Department of Microbiology, Ambrose Alli University, Ekpoma, Nigeria.

Adesola Yinka-Ogunleye (A)

Nigeria Centre for Disease Control, Abuja, Nigeria.

Rashid Ansumana (R)

School of Community Health Sciences, Njala University, Bo, Sierra Leone.

Margaret J Thomason (MJ)

Centre for Clinical Microbiology, Division of Infection and Immunity, University College London, London, UK.

Danny Asogun (D)

Institute of Lassa Fever Research and Control, Irrua Specialist Teaching Hospital, Irrua, Nigeria.

Chikwe Ihekweazu (C)

Nigeria Centre for Disease Control, Abuja, Nigeria.

Elisabeth Fichet-Calvet (E)

Department of Virology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.

Richard A Kock (RA)

The Royal Veterinary College, University of London, Hatfield, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH